Stress and Metabolism: Epinephrine Flashcards
Adrenal medulla synthesizes
EPI or NE
Substrates to EPI and NE are
tyrosine or phanylalanine (aa derivatives)
tyrosine hydroxylase
converts tyrosine to DOPA
Rate-limiting step in catecholamine synthesis
Tyrosine hyroxylase conversion of tyrosine to DOPA
Negative Feedback
EPI and NE inhibit tyrosine hydroxylase
DOPA is converted to dopamine and transferred to
chromaffin granule
Within the chromaffin granule, dopamine-hydroxylase catalyzes
dopamine to NE
In EPI producing cells, NE enters the cytosol and PNMT
converts NE to EPI
PNMT is located
in the cytosol of EPI producing cells only
Synthesis of PNMT is stimulated by
HIgh levels of cortisol during STRESS
How do high levels of cortisol reach the adrenal medulla
by first flowing by the adrenal cortex where cortisol is made
Storage of catecholamines
in the chromaffin granules attached to ATP (to protect them from degradation)
the chromaffin granule is __________
acidic; DBH catalyzes optimally at acidic pH
Activation of the chromaffin granules
SNS fibers innervate the adrenal medulla, stimulation and Ache cause chromaffin granules to fuse with cell membrane and exocytosis occurs (Ca involvement) and EPI concentration will increase
Beta 1 receptor in
heart
alpha 1 receptor in
blood vessels
beta 2 and beta 3 receptors in
tissues with intermediary metabolism, bronchial SM, and heart
beta 2 binds
EPI > NE
Beta 3 binds
NE > EPI
EPI primary action
bind beta 2 receptors for metabolic action: mobilize fuel for stressful situations
Epinephrine is a _____________ to insulin
counter-regulatory hormone
Stress –> SNS activation–>
EPI release from adrenal medulla –> increased fuel
EPI causes
decreased synthesis, increased mobilization, increased gluconeogenesis and glycogenolysis, secretion of glucagon, prevents glucose transport via GLUT4 (Acts like glucagon)
What stimuli will cause the SNS to activate EPI release from adrenal medulla?
trauma, circulatory failure, illness, hypoxia, cold exposure, hypoglycemia
Autocrine control of catecholamines
release of catecholamines into the synaptic cleft allows the catecholamines to bind alpha 2 receptors in the pre-synaptic nerve terminal, preventing further release and prevents excessive secretion of catecholamines
Enzymatic degradation of catecholamines
liver; deamination by MAO and AO
3-O-methylation by COMT
Major metabolites of catecholamine degradation are
VMA and MOPEG
Uptake 1
NE reuptake by presynaptic neuron and either stored in chromaffin granule or degraded by MAO (COMT in liver)
Uptake 2
non-neuronal uptake and degradation by MAO and COMT
Metabolites of EPI and NE are excreted in
urine
Pheochromocytoma
adrenal medulla tumor producing excessive catecholamines
Pheochromocytoma symptoms
increased HR, HTN, tachycardia, headache, sweating, anxiousness, orthostatic hypertension, excessive adrenergic tone, urinary catecholamines
Pheochromocytoma treatment
removal of tumor and replacement of mineral/glucocorticoids (not usually NE or EPI)